GI & Endoscopy

Takeda Pharmaceuticals reported underlying revenue growth of 6.9 percent from fiscal year 2015 to fiscal year 2016.

Harrisburg (Pa.) Gastroenterology is notifying patients of a potential data breach exposing 93,323 patient records, Healthcare IT News reports.

A study presented at Digestive Disease Week 2017 examined patient satisfaction with irritable bowel syndrome treatment.

Here are six updates on GI companies from the past week.

Masi Khaja, MD, is a gastroenterologist at Grand Junction-based Gastroenterology Associates of Western Colorado.

A study presented at Digestive Disease Week 2017 featured an autonomously controlled capsule robot that could change the public's perception of colonoscopy.

Pfizer published results from its phase III oral clinical trials for tofacitinib in ulcerative colitis in The New England Journal of Medicine.

A study published in Cancer examined if patient navigation impacted colonoscopy outcomes.

The American Gastroenterological Association announced the recipients of its 2017 annual recognition awards.

Array BioPharma and Merck formed a clinical trial collaboration agreement to investigate the safety and efficacy of Array's binimetinib, a MEK inhibitor, with Merck's Keytruda, an anti-PD-1 therapy, in metastatic colorectal cancer patients with microsatellite stable tumors.